# Stifel Upgrades Tandem to Buy and Downgrades Insulet on Pump Trends

By Enna Lee

Canonical URL: https://www.tokenpost.com/news/investing/60751
Published: 2026-11-18T18:43:57.000Z
Updated: 2026-11-18T18:43:57.000Z
Section: Investing

> Stifel linked both rating moves to survey results indicating recent trends in tubeless insulin pumps.

Stifel upgraded Tandem Diabetes Care (TNDM) to Buy from Hold and downgraded Insulet Corporation (PODD), linking the moves to survey results indicating recent trends in the tubeless insulin-pump market.

The rating actions came after the U.S. Food and Drug Administration (FDA) [cleared a tubeless version of Tandem’s Mobi insulin-delivery system](<https://www.tokenpost.com/news/regulation/56806>).



## Links in this article

- [cleared a tubeless version of Tandem’s Mobi insulin-delivery system](https://www.tokenpost.com/news/regulation/56806)
